SCHEMBL24089922

SCHEMBL24089922

O=c1c2cc(F)ccc2nc(Nc2ccc(Cl)cc2)n1-c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.47
ALDH1A1 P00352 1/20 0.43
ALOX12 P18054 1/20 0.42
MAT2A P31153 4/20 0.41
GRM1 Q13255 1/20 0.41
HTR7 P34969 1/20 0.40
CYP1A2 P05177 1/20 0.40
METAP2 P50579 1/20 0.40
PRMT5 O14744 1/20 0.39
MDM2 Q00987 1/20 0.39
TDO2 P48775 1/20 0.39
IDO2 Q6ZQW0 1/20 0.39
JUN P05412 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23065259 0.92 ALDH1A1 (0.48) ALDH1A1ALOX12MAT2AGRM1PRMT5
SCHEMBL24090095 0.92 PIK3CD (0.50) PIK3CDALOX12CYP1A2METAP2MDM2
SCHEMBL24111022 0.90 PIK3CD (0.42) PIK3CDGRM1HTR7CYP1A2TDO2
SCHEMBL30103245 0.89 PIK3CD (0.50) PIK3CDALDH1A1ALOX12CYP1A2METAP2
SCHEMBL23958245 0.89 PIK3CD (0.50) PIK3CDALDH1A1ALOX12CYP1A2METAP2
SCHEMBL29623145 0.87 ALDH1A1 (0.48) ALDH1A1ALOX12MAT2APRMT5MDM2
SCHEMBL24089900 0.87 ALDH1A1 (0.48) ALDH1A1ALOX12MAT2APRMT5MDM2
SCHEMBL24089988 0.87 PIK3CD (0.46) PIK3CDALDH1A1ALOX12HTR7CYP1A2
SCHEMBL24110982 0.87 PIK3CD (0.43) PIK3CDHTR7
SCHEMBL24089943 0.86 PIK3CD (0.47) PIK3CDALOX12CYP1A2METAP2MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352366-B2 2-aminoquinazolinone derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-06-07 US disclosed
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-05-12 US disclosed
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, CRKL PIK3CD 4554/4885ALDH1A1 645/4885ALOX12 3008/4885
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, SLC26A3 PIK3CD 4497/4885ALDH1A1 739/4885ALOX12 3295/4885
US-11352366-B2 2-aminoquinazolinone derivative CNKSR1, HAX1, SLC26A3 PIK3CD 4497/4885ALDH1A1 739/4885ALOX12 3295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.